Product
Neoantigen vaccine
1 clinical trial
1 indication
Indication
Hepatocellular CarcinomaClinical trial
An Open, Single-center, Multiple-dose, Dose-increasing and Dose-expanding Clinical Study to Observe and Evaluate the Safety, Tolerance, Immunokinetics and Preliminary Effectiveness of ABOR2014 Injection (IPM511) in the Treatment of Advanced Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2024-12-31